These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 24037912)
1. Association between p53 Arg72Pro polymorphism and thyroid cancer risk: a meta-analysis. Wu B; Guo D; Guo Y Tumour Biol; 2014 Jan; 35(1):561-5. PubMed ID: 24037912 [TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and risk of glioma. Zhang F; Li D; Li Y; Li H; Sun J; Li X; Li X Tumour Biol; 2014 Jan; 35(1):747-51. PubMed ID: 24046089 [TBL] [Abstract][Full Text] [Related]
3. Association between TP53 Arg72Pro polymorphism and thyroid carcinoma risk. Wang F; Wang P; Wang B; Fu ZJ; Yuan Y; Yan SL; Zhao WJ; Wang YG Tumour Biol; 2014 Mar; 35(3):2723-8. PubMed ID: 24375191 [TBL] [Abstract][Full Text] [Related]
4. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk. Liu ZH; Bao ED Mol Biol Rep; 2013 Mar; 40(3):2389-95. PubMed ID: 23184052 [TBL] [Abstract][Full Text] [Related]
5. Association between the p53 codon 72 Arg/Pro polymorphism and hepatocellular carcinoma risk. Lv L; Wang P; Zhou X; Sun B Tumour Biol; 2013 Jun; 34(3):1451-9. PubMed ID: 23564481 [TBL] [Abstract][Full Text] [Related]
6. Association between TP53 Arg72Pro polymorphism and hepatocellular carcinoma risk: a meta-analysis. Xu CT; Zheng F; Dai X; Du JD; Liu HR; Zhao L; Li WM Asian Pac J Cancer Prev; 2012; 13(9):4305-9. PubMed ID: 23167333 [TBL] [Abstract][Full Text] [Related]
7. Associations between P53 Arg72Pro and development of digestive tract cancers: a meta-analysis. Liu L; Wang K; Zhu ZM; Shao JH Arch Med Res; 2011 Jan; 42(1):60-9. PubMed ID: 21376265 [TBL] [Abstract][Full Text] [Related]
8. p.Arg72Pro polymorphism of P53 and breast cancer risk: a meta-analysis of case-control studies. Diakite B; Kassogue Y; Dolo G; Wang J; Neuschler E; Kassogue O; Keita ML; Traore CB; Kamate B; Dembele E; Nadifi S; Murphy RL; Doumbia S; Hou L; Maiga M BMC Med Genet; 2020 Oct; 21(1):206. PubMed ID: 33076844 [TBL] [Abstract][Full Text] [Related]
9. p53 codon 72 polymorphism and hematological cancer risk: an update meta-analysis. Weng Y; Lu L; Yuan G; Guo J; Zhang Z; Xie X; Chen G; Zhang J PLoS One; 2012; 7(9):e45820. PubMed ID: 23029260 [TBL] [Abstract][Full Text] [Related]
10. P53 codon 72 polymorphism, human papillomavirus infection, and their interaction to oral carcinoma susceptibility. Hou J; Gu Y; Hou W; Wu S; Lou Y; Yang W; Zhu L; Hu Y; Sun M; Xue H BMC Genet; 2015 Jun; 16():72. PubMed ID: 26123760 [TBL] [Abstract][Full Text] [Related]
11. Association between the TP53 codon 72 polymorphism and risk of oral squamous cell carcinoma in Asians: a meta-analysis. Zeng XT; Luo W; Geng PL; Guo Y; Niu YM; Leng WD BMC Cancer; 2014 Jun; 14():469. PubMed ID: 24969046 [TBL] [Abstract][Full Text] [Related]
12. Association between the P53 codon 72 polymorphism and nasopharyngeal cancer risk. Cai K; Wang Y; Zhao X; Bao X Tumour Biol; 2014 Mar; 35(3):1891-7. PubMed ID: 24114013 [TBL] [Abstract][Full Text] [Related]
13. The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies. Tian X; Dai S; Sun J; Jiang S; Jiang Y Oncotarget; 2017 Jan; 8(1):1156-1165. PubMed ID: 27901479 [TBL] [Abstract][Full Text] [Related]
14. Association between p53 codon 72 polymorphism and cervical cancer risk among Asians: a HuGE review and meta-analysis. Zhou X; Gu Y; Zhang SL Asian Pac J Cancer Prev; 2012; 13(10):4909-14. PubMed ID: 23244080 [TBL] [Abstract][Full Text] [Related]
15. Meta-analysis demonstrates association between Arg72Pro polymorphism in the P53 gene and susceptibility to keloids in the Chinese population. Wu Y; Wang B; Li YH; Xu XG; Luo YJ; Chen JZ; Wei HC; Gao XH; Chen HD Genet Mol Res; 2012 Jun; 11(2):1701-11. PubMed ID: 22843046 [TBL] [Abstract][Full Text] [Related]
16. Association between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studies. Tian X; Dai S; Sun J; Jiang S; Jiang Y Sci Rep; 2016 Apr; 6():24097. PubMed ID: 27053289 [TBL] [Abstract][Full Text] [Related]
17. TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis. Jiang DK; Yao L; Wang WZ; Peng B; Ren WH; Yang XM; Yu L World J Gastroenterol; 2011 Mar; 17(9):1227-33. PubMed ID: 21448430 [TBL] [Abstract][Full Text] [Related]
18. Association between p53 Arg72Pro polymorphism and colorectal cancer risk in Asian population: a meta-analysis. Zhang Y; Zhang D; Zhao L; Sun L; Dong Q; Cheng L; Cheng R Curr Probl Cancer; 2018 Nov; 42(6):582-592. PubMed ID: 30316510 [TBL] [Abstract][Full Text] [Related]
19. Association of p53 Arg72Pro polymorphism with gastric cancer: a meta-analysis. Tang W; Zhou X; Nie S; Yang Z; Zhu H; Wu X; Zhao R; Luo Y Biomarkers; 2012 Nov; 17(7):597-603. PubMed ID: 22780299 [TBL] [Abstract][Full Text] [Related]
20. TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis. Jiang DK; Yao L; Ren WH; Wang WZ; Peng B; Yu L Med Oncol; 2011 Dec; 28(4):1129-35. PubMed ID: 20552298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]